PYROXD1

Chr 12

pyridine nucleotide-disulphide oxidoreductase domain 1

Also known as: MFM8

This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.97
Clinical SummaryPYROXD1
🧬
Gene-Disease Validity (ClinGen)
myofibrillar myopathy 8 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
31 unique Pathogenic / Likely Pathogenic· 359 VUS of 740 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.97LOEUF
pLI 0.000
Z-score 1.69
OE 0.64 (0.440.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.10Z-score
OE missense 0.98 (0.891.09)
252 obs / 256.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.64 (0.440.97)
00.351.4
Missense OE?0.98 (0.891.09)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 17 / 26.4Missense obs/exp: 252 / 256.4Syn Z: 0.03
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongPYROXD1-related early-onset myopathy with internalised nuclei and myofibrillar disorganizationLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7034th %ile
GOF
0.6150th %ile
LOF
0.2678th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

740 submitted variants in ClinVar

Classification Summary

Pathogenic17
Likely Pathogenic14
VUS359
Likely Benign224
Benign95
Conflicting13
17
Pathogenic
14
Likely Pathogenic
359
VUS
224
Likely Benign
95
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
3
1
0
17
Likely Pathogenic
12
2
0
0
14
VUS
28
310
20
1
359
Likely Benign
0
9
102
113
224
Benign
0
0
91
4
95
Conflicting
13
Total53324214118722

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

41 pathogenic / likely-pathogenic (of 52) ClinVar copy-number / structural variants overlap PYROXD1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PYROXD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →